Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
Type:
Grant
Filed:
November 13, 2013
Date of Patent:
July 8, 2014
Assignee:
GNOSIS S.p.A.
Inventors:
Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin
Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
Type:
Application
Filed:
November 13, 2013
Publication date:
March 13, 2014
Applicant:
GNOSIS S.P.A.
Inventors:
Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin
Abstract: The present invention provides a shark-like chondroitin sulphate and a process for the preparation thereof. In particular, the present invention relates to a shark-like chondroitin sulphate, having a very low amount of 4-sulphate, a high charge density and a biological activity comparable to natural chondroitin sulphates. The invention also relates to a process for the preparation of said shark-like chondroitin sulphate affording substantially higher productivities and better reproducibility of product quality. The shark-like chondroitin sulphate of the invention shows a high molecular mass and its in vitro biological and anti-inflammatory effectiveness has been shown to be comparable to that of natural products making this polysaccharide potentially useful as a drug in pharmaceutical preparations and nutraceuticals.
Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
Type:
Grant
Filed:
June 24, 2011
Date of Patent:
December 17, 2013
Assignee:
Gnosis S.p.A.
Inventors:
Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin
Abstract: The present invention provides a shark-like chondroitin sulphate and a process for the preparation thereof. In particular, the present invention relates to a shark-like chondroitin sulphate, having a very low amount of 4-sulphate, a high charge density and a biological activity comparable to natural chondroitin sulphates. The invention also relates to a process for the preparation of said shark-like chondroitin sulphate affording substantially higher productivities and better reproducibility of product quality. The shark-like chondroitin sulphate of the invention shows a high molecular mass and its in vitro biological and anti-inflammatory effectiveness has been shown to be comparable to that of natural products making this polysaccharide potentially useful as a drug in pharmaceutical preparations and nutraceuticals.
Abstract: Chondroitin is produced by culturing a recombinant microorganism which is obtained by inactivation of a gene encoding an enzyme responsible for addition of fructose residues to the linear chondroitin polysaccharide in a microorganism producing a fructosylated derivative of chondroitin.
Type:
Application
Filed:
June 24, 2011
Publication date:
January 12, 2012
Applicant:
GNOSIS S.P.A.
Inventors:
Antonio Trilli, Immacolata Busiello, Simona Daly, Francesca Bagatin
Abstract: The present invention relates to folates, compositions and uses thereof; In particular, this invention describes a crystalline or amorphous compound which is a substituted or unsubstituted folate or a reduced folate, or the natural or unnatural isomers thereof, of at least one organic base, as well as compositions and uses thereof. The compounds of the invention show a long lasting stability as well as a peculiarly high water-solubility.
Type:
Grant
Filed:
February 20, 2008
Date of Patent:
May 24, 2011
Assignee:
GNOSIS S.p.A.
Inventors:
Ermanno Valoti, Davide Bianchi, Marco Valetti
Abstract: The use of S-adcnosylmcthioninc (SAM) in combination with supcmxidc dismutase (SOD) for the preparation of medicaments for the treatment of Alzheimer's disease.
Type:
Application
Filed:
February 25, 2009
Publication date:
January 27, 2011
Applicant:
GNOSIS S.P.A.
Inventors:
Sigfrido Scarpa, Andrea Fuso, Rosellina Damiani, Mauro Rossini
Abstract: A process for the preparation of vitamin K2 (MK-7) comprising the culture of Bacillus subtilis mutant strain GN13/72-DSM 17766 deposited on Dec. 5, 2005 at the DSMZ.
Type:
Grant
Filed:
December 8, 2006
Date of Patent:
May 18, 2010
Assignee:
GNOSIS S.p.A.
Inventors:
Alberto Benedetti, Simona Daly, Roberto Xaiz, Hermes Pagani
Abstract: The present invention relates to folates, compositions and uses thereof; In particular, this invention describes a crystalline or amorphous compound which is a substituted or unsubstituted folate or a reduced folate, or the natural or unnatural isomers thereof, of at least one organic base, as well as compositions and uses thereof. The compounds of the invention show a long lasting stability as well as a peculiarly high water-solubility.
Type:
Application
Filed:
February 20, 2008
Publication date:
August 20, 2009
Applicant:
GNOSIS S.p.A.
Inventors:
Ermanno Valoti, Davide Bianchi, Marco Valetti